Author

CM Booth

Observed names: C. M. Booth, C.M. Booth

Institution: Queen's University

Observed institutions: Queen's University, Massachusetts General Hospital, Colchester Hospital, Colchester Hospital University NHS Foundation Trust

OpenAlex ID: A5111000486

Nurse-Led Phone Call Follow-Up Clinics Are Effective for Patients With Prostate Cancer

2017 · RG Casey, L Powell, et al. · Journal of Patient Experience · 31

Adoption of adjuvant chemotherapy for non-small cell lung cancer: A population-based outcomes study.

2010 · C. M. Booth, F. A. Shepherd, et al. · Journal of Clinical Oncology · 10

The current status of National Cancer Control Plans in Africa: Data from 32 countries

2023 · A.V.C. Manirakiza, F. Rubagumya, et al. · Journal of Cancer Policy · 9

A phase II study of maintenance therapy with temsirolimus (TEM) after response to first-line docetaxel (TAX) chemotherapy in castration-resistant prostate cancer (CRPC).

2011 · U. Emmenegger, S. R. Berry, et al. · Journal of Clinical Oncology · 1

221P Real-world outcomes of first-line atezolizumab-bevacizumab for unresectable hepatocellular carcinoma: A population-based cohort study in Ontario

2026 · G.T. Moffat, N. Chen, et al. · Annals of Oncology

The impact of time to adjuvant chemotherapy (AC) on survival in colorectal cancer (CRC): A systematic review and meta-analysis.

2011 · M. Raphael, J. J. Biagi, et al. · Journal of Clinical Oncology

Abstract PD03-04: Effects of Diabetes (DM), Hypertension (HTN) and Coronary Artery Disease (CAD) on Prognosis after 5 Years of Adjuvant Tamoxifen (TAM) and on Treatment Outcomes with the Use of Extended Letrozole (LET): NCIC CTG MA.17

2010 · RA Goodwin, R Jamal, et al. · Cancer Research

Works count: 7

Citation count: 51

H-index: 3

I10-index: 2